skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Methods, potentials, and limitations of gene delivery to regenerate central nervous system cells

Review

(2958) Views  (727) Full article downloads

Authors: Arvind Kumar, Tryambak D Singh, Santosh K Singh, Satya Prakash

Published Date May 2009 Volume 2009:3 Pages 245 - 256
DOI: http://dx.doi.org/10.2147/BTT.S4672

Arvind Kumar1, Tryambak D Singh2, Santosh K Singh3, Satya Prakash4

1School of Biotechnology, Faculty of Science; 2Department of Medicinal Chemistry, Institute of Medical Sciences; 3Centre of Experimental Medicine and Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India; 4Biomedical Technology and Cell Therapy Research Laboratory, Department of Biomedical Engineering and Physiology, Artificial Cells and Organs Research Centre, Faculty of Medicine, McGill University, Montreal, Québec, Canada

Abstract: This review evaluates methods, success and limitations of transgenes delivery in central nervous system (CNS). Both viral and nonviral (such as liposome mediated) methods, expression and stability of transgenes have been discussed. The controlled expression and delivery techniques of transgene at the injured or diseased sites have also been discussed. Mifepristone (RU486) and tetracycline-based switch system for controlled expression could be a very useful tool for clinical purposes. Here we emphasized the importance and consequences of viral- and nonviral-mediated transgenes transfer and therapeutic ability along with advantages of controlled expressions.

Keywords: transgenes, viral vector, nonviral vector, RU486, tetracycline, CNS






 

Other articles by Professor Satya Prakash

A novel method for synthesizing PEGylated chitosan nanoparticles: strategy, preparation, and in vitro analysis
A novel polyethyleneimine-coated adeno-associated virus-like particle formulation for efficient siRNA delivery in breast cancer therapy: preparation and in vitro analysis
Angiopoietin-1-expressing adipose stem cells genetically modified with baculovirus nanocomplex: investigation in rat heart with acute infarction
Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells
Diet-induced metabolic hamster model of nonalcoholic fatty liver disease
Gut microbiota: next frontier in understanding human health and development of biotherapeutics
Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysis
Mitotic and antiapoptotic effects of nanoparticles coencapsulating human VEGF and human angiopoietin-1 on vascular endothelial cells
Potentials and limitations of microorganisms as renal failure biotherapeutics


Readers of this article also read:

Therapeutic vaccines for malignant brain tumors
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Anti-interleukin-2 receptor antibodies—basiliximab and daclizumab—for the prevention of acute rejection in renal transplantation
Pharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine
Hepatitis B virus and Homo sapiens proteomewide analysis: A profusion of viral peptide overlaps in neuron-specific human proteins
Palliative treatment of malignant ascites: profile of catumaxomab
Potential sources of stem cells as a regenerative therapy for Parkinson's disease
Viral vectors for cystic fibrosis gene therapy: What does the future hold?
Isolation, characterization, and gene expression analysis of Wharton’s jelly-derived mesenchymal stem cells under xeno-free culture conditions
The Application of Clinical Genetics
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University

  • Journal Indexing

    See where all the Dove Press journals are indexed